These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8757618)

  • 1. Transduction of specific inhibition of HuT 78 human T cell chemotaxis by type I vasoactive intestinal peptide receptors.
    Xia M; Gaufo GO; Wang Q; Sreedharan SP; Goetzl EJ
    J Immunol; 1996 Aug; 157(3):1132-8. PubMed ID: 8757618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor.
    Xia M; Sreedharan SP; Bolin DR; Gaufo GO; Goetzl EJ
    J Pharmacol Exp Ther; 1997 May; 281(2):629-33. PubMed ID: 9152366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane.
    Xia M; Leppert D; Hauser SL; Sreedharan SP; Nelson PJ; Krensky AM; Goetzl EJ
    J Immunol; 1996 Jan; 156(1):160-7. PubMed ID: 8598457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell vasoactive intestinal peptide receptor subtype expression differs between granulomas and spleen of schistosome-infected mice.
    Metwali A; Elliott D; Blum AM; Li J; Sandor M; Weinstock JV
    J Immunol; 1996 Jul; 157(1):265-70. PubMed ID: 8683124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity of effects of vasoactive intestinal peptide on macrophages and lymphocytes in compartmental immune responses.
    Goetzl EJ; Pankhaniya RR; Gaufo GO; Mu Y; Xia M; Sreedharan SP
    Ann N Y Acad Sci; 1998 May; 840():540-50. PubMed ID: 9629281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar involvement of VIP receptor type I and type II in lymphocyte chemotaxis.
    Schratzberger P; Geiseler A; Dunzendorfer S; Reinisch N; Kähler CM; Wiedermann CJ
    J Neuroimmunol; 1998 Jul; 87(1-2):73-81. PubMed ID: 9670847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide.
    Johnston JA; Taub DD; Lloyd AR; Conlon K; Oppenheim JJ; Kevlin DJ
    J Immunol; 1994 Aug; 153(4):1762-8. PubMed ID: 7519212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of vasoactive intestinal peptide receptor subtypes in the lacrimal gland and their signal-transducing components.
    Hodges RR; Zoukhri D; Sergheraert C; Zieske JD; Dartt DA
    Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):610-9. PubMed ID: 9071214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.
    Delgado M; Reduta A; Sharma V; Ganea D
    J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.
    Summers MA; O'Dorisio MS; Cox MO; Lara-Marquez M; Goetzl EJ
    J Pharmacol Exp Ther; 2003 Aug; 306(2):638-45. PubMed ID: 12750439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
    Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
    Goursaud S; Pineau N; Becq-Giraudon L; Gressens P; Muller JM; Janet T
    J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide enhancement of antigen-induced differentiation of a cultured line of mouse thymocytes.
    Pankhaniya R; Jabrane-Ferrat N; Gaufo GO; Sreedharan SP; Dazin P; Kaye J; Goetzl EJ
    FASEB J; 1998 Jan; 12(1):119-27. PubMed ID: 9438417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors.
    Cunha-Reis D; Ribeiro JA; Sebastião AM
    Brain Res; 2005 Jul; 1049(1):52-60. PubMed ID: 15935995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of vasoactive intestinal peptide on chemotaxis of bronchial epithelial cells].
    Guan CX; Zhang CQ; Qin XQ; Luo ZQ; Zhou FW; Sun XH
    Sheng Li Xue Bao; 2002 Apr; 54(2):103-6. PubMed ID: 11973586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart.
    Sawmiller DR; Henning RJ; Cuevas J; Dehaven WI; Vesely DL
    Neuropeptides; 2004 Oct; 38(5):289-97. PubMed ID: 15464194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.